Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;22(3):224-31.
doi: 10.1053/j.ackd.2014.10.004.

Atherosclerotic renal artery stenosis: current status

Affiliations
Review

Atherosclerotic renal artery stenosis: current status

Soon Hyo Kwon et al. Adv Chronic Kidney Dis. 2015 May.

Abstract

Atherosclerotic renal artery stenosis (ARAS) remains a major cause of secondary hypertension and kidney failure. Randomized prospective trials show that medical treatment should constitute the main therapeutic approach in ARAS. Regardless of intensive treatment and adequate blood pressure control, however, renal and extrarenal complications are not uncommon. Yet, the precise mechanisms, accurate detection, and optimal treatment in ARAS remain elusive. Strategies oriented to early detection and targeting these pathogenic pathways might prevent development of clinical end points. Here, we review the results of recent clinical trials, current understanding of the pathogenic mechanisms, novel imaging techniques to assess kidney damage in ARAS, and treatment options.

Keywords: Atherosclerosis; Hypertension; Inflammation; Ischemia; Renal artery obstruction.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic of interactive mechanisms responsible for kidney injury in atherosclerotic renal artery stenosis (ARAS). A critical renovascular occlusion activates the renin-angiotensin-aldosterone system (RAAS), elicits hypoxia, and increases oxidative stress. Together with atherosclerosis this process induces parenchymal inflammation, fibrosis, microvascular loss, and kidney dysfunction.
Figure 2
Figure 2
Representative 3D micro-computed tomography images from a normal (left) and a stenotic swine kidney, showing a decreased number of cortical and medullary microvessels in the hypo-perfused kidney.
Figure 3
Figure 3
Blood oxygen-level-dependent (BOLD) parametric map in normal pigs (left) and in a swine model of atherosclerotic renal artery stenosis (ARAS) (right) obtained before and after injection of furosemide, which inhibits oxygen-dependent tubular transport and thereby increases kidney oxygenation. Arrows indicate the medullary regions, and crosses blood vessels. Medullary R2* was higher (more red) both at baseline and after furosemide in ARAS, suggesting greater hypoxia and blunted response to furosemide compared to normal pig kidneys.

References

    1. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36(3):443–451. - PubMed
    1. Guo H, Kalra PA, Gilbertson DT, et al. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation. 2007;115(1):50–58. - PubMed
    1. Ebrahimi B, Li Z, Eirin A, Zhu XY, Textor SC, Lerman LO. Addition of endothelial progenitor cells to renal revascularization restores medullary tubular oxygen consumption in swine renal artery stenosis. Am J Physiol Renal Physiol. 2012;302(11):F1478–1485. - PMC - PubMed
    1. Krier JD, Ritman EL, Bajzer Z, Romero JC, Lerman A, Lerman LO. Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function. Am J Physiol Renal Physiol. 2001;281(4):F630–638. - PubMed
    1. Chade AR, Zhu XY, Krier JD, et al. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells. 2010;28(6):1039–1047. - PMC - PubMed

Publication types

MeSH terms